BeStock  

West Pharmaceutical Services WST

US equityMarket cap rank #483Medical Instruments & Supplies
$367.87 −$2.89 (-0.78%)
Market open · Oct 1, 11:50 am ET · After hours $370.76 0.00%
Open$371.00
Prev close$370.76
Day range$366.19 – $369.90
Volume131.8K
Market cap$25.89B
P/E (TTM)47.1
Dividend yield0.24%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$872.30M+13.8% YoY
Operating profit$191.90M+20.8% YoY
Net profit$154.00M+16.8% YoY
Diluted EPS$2.15+18.1% YoY
Free cash flow$80.80M-20.7% YoY
Operating cash flow$124.00M

Revenue, last 8 quarters

$746.9MSep '24$748.8MDec '24$698.0MMar '25$766.5MJun '25$804.6MSep '25$805.0MDec '25$844.9MMar '26$872.3MJun '26

Net profit, last 8 quarters

$136.0MSep '24$130.1MDec '24$89.8MMar '25$131.8MJun '25$140.0MSep '25$132.1MDec '25$138.8MMar '26$154.0MJun '26

Diluted EPS by quarter

1.85Sep '241.78Dec '241.23Mar '251.82Jun '251.92Sep '251.82Dec '251.92Mar '262.15Jun '26

Free cash flow by quarter

$98.8MSep '24$85.2MDec '24$58.1MMar '25$101.9MJun '25$133.9MSep '25$175.0MDec '25$47.2MMar '26$80.8MJun '26

Annual revenue

$2.1BFY20$2.8BFY21$2.9BFY22$2.9BFY23$2.9BFY24$3.1BFY25

Profitability & balance sheet

Gross margin36.8%
Operating margin21.7%
Net margin17.0%
Return on equity19.1%
Return on assets14.1%
Return on invested capital16.9%
Current ratio2.82
Liabilities / assets26.6%
Cash & investments$435.80M
Total debt$291.20M
Net cash (debt)$144.60M
Free cash flow / sales13.1%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $872.30M $844.90M $3.07B $805.00M $804.60M
Total Operating Revenue $872.30M $844.90M $3.07B $805.00M $804.60M
Cost of Revenue $543.10M $548.50M $1.97B $501.10M $510.30M
Gross Profit $329.20M $296.40M $1.10B $303.90M $294.30M
Operating Expense $137.30M $115.30M $467.90M $128.80M $119.80M
Selling and Admin Expenses $117.60M $99.50M $393.60M $107.00M $102.70M
Research & Development $19.70M $15.80M $74.30M $21.80M $17.10M
Operating Profit $191.90M $181.10M $636.10M $175.10M $174.50M
Net Non-Operating Interest Income (Expense) $1.20M $3.20M $17.00M $5.30M $4.50M
Non-Operating Interest Income $3.80M $5.10M $17.50M $5.10M $4.70M
Non-Operating Interest Expense $2.60M $1.90M $500,000.00 -$200,000.00 $200,000.00
Other Income (Expense) -$13.00M -$4.20M -$52.20M -$18.90M -$7.10M
Gain on Sale of Security -$2.90M $800,000.00 -$8.40M -$2.80M -$2.70M
Special Income (Charges) -$9.40M -$4.80M -$41.50M -$15.30M -$3.90M
-Less:Restructuring and Mergern & Acquisition $5.50M $4.80M $33.30M $8.50M $3.60M
-Less:Write Off $3.90M – $4.50M $3.10M $300,000.00
Other Non-Operating Income (Expenses) -$700,000.00 -$200,000.00 -$2.30M -$800,000.00 -$500,000.00
Pretax Profit $180.10M $180.10M $600.90M $161.50M $171.90M
Tax $32.20M $44.70M $121.60M $33.30M $34.00M
Earnings from Equity Interest Net of Tax $6.10M $3.40M $14.40M $3.90M $2.10M
Net Profit $154.00M $138.80M $493.70M $132.10M $140.00M
Profit from Continuing Operations $154.00M $138.80M $493.70M $132.10M $140.00M
Net Income to Parent Company $154.00M $138.80M $493.70M $132.10M $140.00M
Net Income to Common Stockholders $154.00M $138.80M $493.70M $132.10M $140.00M
Basic EPS $2.17 $1.93 $6.83 $1.83 $1.94
Diluted EPS $2.15 $1.92 $6.79 $1.82 $1.92
Dividend Per Share $0.22 $0.22 $0.85 $0.22 $0.21
-Less:Impairment of Capital Assets – – $3.70M – –
-Gain on Sale of Property/Plant/Equipment – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $4.08B $4.11B $4.27B $4.27B $4.11B
Total Current Assets $1.81B $1.83B $1.98B $1.98B $1.82B
Cash and Cash Equivalents & Short-Term Investments $435.80M $521.40M $791.30M $791.30M $628.50M
-Cash and Cash Equivalents $435.80M $521.40M $791.30M $791.30M $628.50M
Receivables $712.00M $685.60M $574.40M $574.40M $625.00M
-Accounts Receivable $712.00M $685.60M $574.40M $574.40M $625.00M
Inventory $447.40M $452.60M $443.90M $443.90M $438.00M
Other Current Assets $212.30M $167.20M $168.60M $168.60M $131.80M
Total Non-Current Assets $2.27B $2.28B $2.29B $2.29B $2.28B
Net PPE $1.79B $1.81B $1.84B $1.84B $1.84B
-Gross PPE $3.35B $3.33B $3.34B $3.34B $3.33B
-Accumulated Depreciation -$1.56B -$1.52B -$1.50B -$1.50B -$1.49B
Investments and Advances $207.70M $209.20M $212.30M $212.30M $220.90M
-Long Term Equity Investment $207.70M $209.20M $212.30M $212.30M $220.90M
Goodwill and Other Intangible Assets $115.10M $116.20M $117.70M $117.70M $119.50M
-Goodwill $108.70M $109.20M $110.00M $110.00M $110.60M
-Other Intangible Assets $6.40M $7.00M $7.70M $7.70M $8.90M
Non-Current Deferred Assets $72.30M $63.90M $38.40M $38.40M $27.90M
Other Non-Current Assets $82.80M $81.30M $80.10M $80.10M $75.80M
Total Liabilities $1.09B $1.12B $1.09B $1.09B $1.05B
Total Current Liabilities $640.50M $674.00M $654.90M $654.90M $635.40M
Payables $317.40M $331.20M $317.60M $317.60M $289.10M
-Accounts Payable $252.70M $252.30M $253.70M $253.70M $255.80M
-Total Tax Payable $64.70M $78.90M $48.10M $48.10M $33.30M
Current Accrued Expenses $131.10M $119.20M $193.80M $193.80M $111.80M
Short-Term Debt and Capital Lease Obligation $20.90M $21.40M $22.70M $22.70M $21.40M
-Current Capital Lease Obligation $20.90M $21.40M $22.70M $22.70M $21.40M
Other Current Liabilities $171.10M $202.20M $55.60M $55.60M $213.10M
Total Non-Current Liabilities $445.70M $445.40M $439.10M $439.10M $418.90M
Long Term Debt and Capital Lease Obligation $291.20M $294.80M $298.40M $298.40M $276.20M
-Long Term Debt $202.90M $202.80M $202.80M $202.80M $202.70M
-Long Term Capital Lease Obligation $88.30M $92.00M $95.60M $95.60M $73.50M
Non-Current Deferred Liabilities $36.30M $34.50M $36.50M $36.50M $36.30M
Employee Benefits $28.30M $28.50M $29.00M $29.00M $31.10M
Other Non-Current Liabilities $89.90M $87.60M $75.20M $75.20M $75.30M
Total Equity $2.99B $2.99B $3.18B $3.18B $3.05B
Stockholders' Equity $2.99B $2.99B $3.18B $3.18B $3.05B
Capital Stock $18.80M $18.80M $18.80M $18.80M $18.80M
-Common Stock $18.80M $18.80M $18.80M $18.80M $18.80M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings $4.62B $4.48B $4.37B $4.37B $4.26B
Less: Treasury Stock $1.51B $1.38B $1.11B $1.11B $1.13B
Gains/Losses Not Affecting Retained Earnings -$140.40M -$125.20M -$105.50M -$105.50M -$102.30M
-Dividends Payable – – $15.80M $15.80M –
Current Provisions – – $1.30M $1.30M –
Current Deferred Liabilities – – $51.90M $51.90M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $124.00M $89.90M $754.80M $251.10M $197.20M
Net cash flow from continuing operations $124.00M $89.90M $754.80M $251.10M $197.20M
Net Income from Continuing Operations $154.00M $138.80M $493.70M $132.10M $140.00M
Depreciation & Depletion & Amortization $46.20M $45.20M $171.40M $47.00M $43.00M
Other Non-Cash Items -$5.00M $1.90M -$2.00M -$100,000.00 $3.40M
Change in Working Capital -$86.00M -$102.90M $79.80M $81.70M $2.10M
Net cash flow from investing -$43.20M -$42.70M -$285.90M -$76.10M -$63.30M
Net Cash Flow from Continuing Investing Activities -$43.20M -$42.70M -$285.90M -$76.10M -$63.30M
Capital Expenditure -$43.20M -$42.70M -$285.90M -$76.10M -$63.30M
Financing Cash Flow -$164.80M -$308.70M -$185.10M -$11.70M -$11.50M
Net Cash Flow from Continuing Financing Activities -$164.80M -$308.70M -$185.10M -$11.70M -$11.50M
Net Issuance Payments Of Debt -$400,000.00 -$300,000.00 -$1.10M -$300,000.00 -$300,000.00
Net Common Stock Issuance -$156.70M -$300.10M -$136.80M -$200,000.00 -$100,000.00
Cash Dividends Paid -$15.70M -$15.80M -$61.20M -$15.80M -$15.10M
Proceeds from Stock Option Exercised $8.80M $7.50M $18.20M $4.60M $4.00M
Ending Cash Balance $435.80M $521.40M $791.30M $791.30M $628.50M
Net Change in Cash -$84.00M -$261.50M $283.80M $163.30M $122.40M
Beginning Cash Balance $521.40M $791.30M $484.60M $628.50M $509.70M
Effect of Exchange Rate Changes -$1.60M -$8.40M $22.90M -$500,000.00 -$3.60M
Free Cash Flow $80.80M $47.20M $468.90M $175.00M $133.90M
Gain/Loss from Continuing Operations – – -$9.90M – –
Deferred Tax – – -$13.70M – –
-Change in Receivables – – $6.90M – –
-Change in Inventory – – -$62.80M – –
-Change in Payables and Accrued Expense – – $17.90M – –
-Change in Other Current Assets – – $9.70M – –
-Change In Other Working Capital – – $108.10M – –
Net Other Financing Charges – – -$4.20M $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on WST.

Leave a comment

Scroll to Top